All In MedTech

FDA Clearance Tracker · P200039-S015

Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) Cathete

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 10, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 10, 2025

Approved

Time to decision

90 days

Received Mar 12, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200039-S015
Device name
Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) Cathete
Applicant location
Santa Clara, CA
Received
Mar 12, 2025
Decided
Jun 10, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200039

Device type

Device class
Class III

Every decision under product code QMG

FDA's approval statement

As written in FDA's record.

the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) Catheter

Source documents

Other decisions for Shockwave Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.